Nucleic Acid Therapeutics Toolbox: Mipomersen, the first gapmer
In this instalment of our Toolbox blog series, we take a closer look at mipomersen (Kynamro®) – the first gapmer therapeutic approved by the FDA.| blog.biosearchtech.com
In this instalment of our Toolbox blog series, we take a closer look at mipomersen (Kynamro®) – the first gapmer therapeutic approved by the FDA.| blog.biosearchtech.com
Discover how pegaptanib, the first aptamer-based drug approved in 2004, revolutionized therapeutics. Learn about its significance in our Nucleic Acid Therapeutics Toolbox blog series.| blog.biosearchtech.com
Find out why we are excited about GalNAc as a means of delivering siRNAs and other therapeutic oligos to the liver.| blog.biosearchtech.com
